MLA 0.00% 8.5¢ medical australia limited

analyst report - significant upside potential

  1. 8,256 Posts.
    Nice report by RB Milestone Group, dated 5th May and posted on the MLA website on 9th May.

    http://www.medaust.com/IRM/Company/ShowPage.aspx?CPID=1102&EID=14071631&PageName=RB Milstone Group Report

    The report echoes the obvious potential astute investors here have jumped all over.

    "Our DCF-based valuation model gives us a price target of A$0.059 with a potential upside of 84.6%. We believe that the stock is attractively priced at current levels with a significant upside potential at this stage."

 
watchlist Created with Sketch. Add MLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.